LOOMIS SAYLES & CO L P Inhibrx Biosciences, Inc. Transaction History

LOOMIS SAYLES & CO L P portfolio value:

$18.39M
portfolio value

LOOMIS SAYLES & CO L P quarter portfolio value change:

+58.15%
quarter

Inhibrx Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -1.11% -11.55K shares 6.63M $17.95 1.02M
Q2 2022 share Decrease -0.40% -4.12K shares -11.41M $11.35 1.03M
Q1 2022 share Increase 0.00% 1.04M shares 23.18M $22.28 1.04M